Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking

Authors

Wagdy M. Eldehna, Egyptian Russian University
Mohamed Fares, Egyptian Russian University
Hany S. Ibrahim, Egyptian Russian University
Mohamed H. Aly, The British University in Egypt
Suher Zada, American University in CairoFollow
Mamdouh M. Ali, National Research Centre
Sahar M. Abou-Seri, Cairo University Faculty of Pharmacy
Hatem A. Abdel-Aziz, King Saud University College of Pharmacy
Dalal A. Abou El Ella, Ain Shams University

Funding Sponsor

Deanship of Scientific Research, King Saud University

Author's Department

Biology Department

Find in your Library

#NAME?

Document Type

Research Article

Publication Title

European Journal of Medicinal Chemistry

Publication Date

6-12-2015

doi

10.1016/j.ejmech.2015.05.040

First Page

89

Last Page

97

Recommended Citation

APA Citation

Eldehna, W. Fares, M. Ibrahim, H. Aly, M. ... (2015). Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking. European Journal of Medicinal Chemistry, 100, 89–97. https://doi.org/10.1016/j.ejmech.2015.05.040

MLA Citation

Eldehna, Wagdy M., et al. "Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking." European Journal of Medicinal Chemistry, vol. 100, 2015, pp. 89–97.
https://doi.org/10.1016/j.ejmech.2015.05.040